Expertise in
16
conditions

Yoshihiro Kakeji

Kobe, JP 
Expertise in
16
conditions
Kobe, JP 

Overview

Yoshihiro Kakeji practices practicing medicine in Kobe, Japan.

Mr. Kakeji is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Stomach Cancer, Colorectal Cancer, Esophageal Cancer, Gastrectomy, and Endoscopy.

He is actively involved in clinical research, co-authoring 547 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Kobe, Japan
Other Locations
Tokyo, Japan
Minato, Japan
Japan
Chuo, 6500017, Japan
Marunouchi, 1000005, Japan
Akashi, 6738558, Japan
Higashi, Japan
Fukuoka, Japan
Tanaka, 6500017, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Placebo-Controlled, Double-Blind Phase 3 Study to Evaluate the Efficacy and Safety of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First-Line Treatment in Patients With Unresectable, Locally Advanced Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
A Randomized, Placebo-Controlled, Double-Blind Phase 3 Study to Evaluate the Efficacy and Safety of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First-Line Treatment in Patients With Unresectable, Locally Advanced Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
Enrollment Status: Completed
Publish Date: July 29, 2025
Intervention Type: Drug, Biological
Study Drugs: Cisplatin, Capecitabine, Paclitaxel, Fluorouracil (5-FU), Oxaliplatin, Tislelizumab
Study Phase: Phase 3

547 Total Publications

Geriatric Nutritional Risk Index Predicts Prognosis of Elderly Gastric Cancer Patients After Non-Curative Endoscopic Treatment.
Geriatric Nutritional Risk Index Predicts Prognosis of Elderly Gastric Cancer Patients After Non-Curative Endoscopic Treatment.
Journal: The Kobe journal of medical sciences
Published: June 10, 2026

Frequently Asked Questions about Yoshihiro Kakeji

Is Yoshihiro Kakeji a top-rated expert for Stomach Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Yoshihiro Kakeji is classified as an Elite expert for Stomach Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Yoshihiro Kakeji participate in research or clinical trials?

Yes. Yoshihiro Kakeji has published 547 articles and abstracts on conditions like Stomach Cancer. You can view a list of Yoshihiro Kakeji's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kakeji's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 60 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile